Lateral subendocardium-involved LGE and septal midwall LGE predicted SCD in DCM, with the risk model showing C-statistic improvement of 0.23 over conventional indicators.
Does the presence of lateral subendocardium-involved and septal midwall late gadolinium enhancement (LGE) on cardiac MRI improve risk stratification for sudden cardiac death in patients with nonischemic dilated cardiomyopathy?
Integrating lateral subendocardium-involved and septal midwall LGE phenotypes on cardiac MRI significantly improves sudden cardiac death risk stratification in nonischemic dilated cardiomyopathy compared to LVEF alone.
Absolute Event Rate: 0% vs 0%
Abstract Aims The prognostic value of late gadolinium enhancement (LGE) phenotypes-particularly subendocardial involvement-for sudden cardiac death (SCD) remains unclear in dilated cardiomyopathy (DCM). Whether LGE phenotype integrating pattern and location can improve SCD risk stratification is an unmet need. Methods and results DCM patients who underwent cardiac MRI were retrospectively enrolled. The endpoint was a composite of SCD and surrogate SCD events. Among 902 patients (mean age 46±14 years, 78.7% men), subendocardium-involved and mid-wall LGE were observed in 129 (14.3%) and 263 (29.1%) patients, predominantly involving the lateral (65.1%) and septal wall (97.7%), respectively. During a median follow-up of 77 months (IQR 40-92 months), 51 (5.7%) patients experienced SCD events. Multivariable analysis identified septal midwall LGE (HR 3.59; 95% CI 1.73-7.47; P = .001) and lateral subendocardium-involved LGE (HR 3.07; 95% CI 1.39-6.75; P = .005) as independent predictors. A three-tier risk stratification model was developed, classifying patients into: lowest risk (neither septal midwall nor lateral subendocardium-involved LGE; reference), intermediate risk (either phenotype alone; HR 4.8, 95% CI 2.2-10.46, P .001), and highest risk (both phenotypes; HR 10.71, 95% CI 3.53-32.46, P .001). The model showed the best improvement in model discrimination and reclassification over left ventricular ejection fraction (C-statistic improvement: 0.23; net reclassification improvement = 0.67; integrative discrimination index = 0.27; all P .05). Conclusions SCD was predicted by both lateral subendocardium-involved LGE and septal midwall LGE in DCM. The novel SCD risk model integrating these phenotypes demonstrated superior prognostic performance compared to conventional prognosticators.
Jia et al. (Sat,) reported a other. Lateral subendocardium-involved LGE and septal midwall LGE predicted SCD in DCM, with the risk model showing C-statistic improvement of 0.23 over conventional indicators.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: